𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of Hepatitis C–Infected Deceased Donors in Liver Transplantation

✍ Scribed by Richard S. Mangus

Book ID
107540544
Publisher
Current Science Inc.
Year
2010
Tongue
English
Weight
147 KB
Volume
9
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes in hepatitis C virus–infected r
Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation
✍ Norah A. Terrault; Mitchell L. Shiffman; Anna S.F. Lok; Sammy Saab; Lan Tong; Ro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In this retrospective study of hepatitis C virus (HCV)-infected transplant recipients in the 9-center Adult to Adult Living Donor Liver Transplantation Cohort Study, graft and patient survival and the development of advanced fibrosis were compared among 181 living donor liver transplant (LDLT) recip

Use of living donor liver transplantatio
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation
✍ Parsia A. Vagefi; Nancy L. Ascher; Chris E. Freise; Jennifer L. Dodge; John P. R 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

The demographics of patients in the United States who undergo living donor liver transplantation (LDLT) versus patients who undergo deceased donor liver transplantation (DDLT) are interesting with respect to the demographics of the donor service areas (DSAs). We examined adult recipients of primary,

Histologic recurrence of chronic hepatit
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation
✍ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We

Living donor liver transplantation for h
Living donor liver transplantation for hepatitis C-related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients
✍ Linsheng Guo; Mauricio Orrego; Hector Rodriguez-Luna; Vijiyan Balan; Thomas Byrn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

The question of possible earlier and more aggressive recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) remains unanswered. To address this issue we retrospectively reviewed virological, histological

The difference in the fibrosis progressi
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age
✍ Nazia Selzner; Nigel Girgrah; Les Lilly; Maha Guindi; Markus Selzner; George The 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Hepatitis C recurs universally after liver transplantation (LT). Whether its progression differs after live donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) is still debated. We retrospectively analyzed 201 consecutive LTs performed at our institution for hepatitis